BRILINTA (ticagrelor) is an antiplatelet medication developed by AstraZeneca, primarily used to reduce the risk of cardiovascular events such as heart attacks or strokes in patients with a history of acute coronary syndrome or those undergoing certain heart procedures. This medication works by preventing blood cells called platelets from clumping together, thereby improving blood flow and reducing the risk of blockages in the arteries.
For a deeper exploration of how BRILINTA 90 MG affects individuals and the underlying mechanisms of its action, visit this comprehensive article: Understanding the Effects of BRILINTA 90 MG by AstraZeneca.
Benefits of BRILINTA 90 MG
The key benefits of BRILINTA 90 MG include:
- Reduced Risk of Cardiovascular Events: It significantly lowers the chances of heart attacks and strokes in at-risk patients.
- Rapid Onset of Action: BRILINTA starts working quickly, which is crucial during emergency situations.
- Long-term Effectiveness: Continuous use helps maintain its protective effects on the cardiovascular system.
Common Side Effects
As with any medication, BRILINTA may cause side effects. The most common include:
- Increased Risk of Bleeding: Patients may experience easy bruising or longer bleeding times.
- Dyspnea: Some patients report shortness of breath while taking this medication.
- Nausea: Gastrointestinal upset can occur in some individuals.
Important Considerations
Before starting BRILINTA, it is essential to:
- Consult a healthcare provider to discuss any potential drug interactions or pre-existing conditions.
- Inform the doctor about any upcoming surgical procedures, as BRILINTA can affect bleeding.
- Adhere to the prescribed dosage and report any unusual side effects to a healthcare professional immediately.
In summary, BRILINTA 90 MG by AstraZeneca is a powerful tool in reducing the risk of serious cardiovascular events. Understanding its effects and observing proper medical guidance can significantly enhance its benefits for patients at risk.